These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 31223443)

  • 1. Discovery of Orally Active Hydroxyethylamine Based SPPL2a Inhibitors.
    Velcicky J; Mathison CJN; Nikulin V; Pflieger D; Epple R; Azimioara M; Cow C; Michellys PY; Rigollier P; Beisner DR; Bodendorf U; Guerini D; Liu B; Wen B; Zaharevitz S; Brandl T
    ACS Med Chem Lett; 2019 Jun; 10(6):887-892. PubMed ID: 31223443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of the First Potent, Selective, and Orally Bioavailable Signal Peptide Peptidase-Like 2a (SPPL2a) Inhibitor Displaying Pronounced Immunomodulatory Effects In Vivo.
    Velcicky J; Bodendorf U; Rigollier P; Epple R; Beisner DR; Guerini D; Smith P; Liu B; Feifel R; Wipfli P; Aichholz R; Couttet P; Dix I; Widmer T; Wen B; Brandl T
    J Med Chem; 2018 Feb; 61(3):865-880. PubMed ID: 29359565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Substrate determinants of signal peptide peptidase-like 2a (SPPL2a)-mediated intramembrane proteolysis of the invariant chain CD74.
    Hüttl S; Helfrich F; Mentrup T; Held S; Fukumori A; Steiner H; Saftig P; Fluhrer R; Schröder B
    Biochem J; 2016 May; 473(10):1405-22. PubMed ID: 26987812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Signal-peptide-peptidase-like 2a is required for CD74 intramembrane proteolysis in human B cells.
    Schneppenheim J; Hüttl S; Kruchen A; Fluhrer R; Müller I; Saftig P; Schneppenheim R; Martin CL; Schröder B
    Biochem Biophys Res Commun; 2014 Aug; 451(1):48-53. PubMed ID: 25035924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of SPPL2a Inhibitors by Multiparametric Analysis of a High-Content Ultra-High-Throughput Screen.
    Zhang X; Götte M; Ibig-Rehm Y; Schuffenhauer A; Kamke M; Beisner D; Guerini D; Siebert D; Bonamy GMC; Gabriel D; Bodendorf U
    SLAS Discov; 2017 Oct; 22(9):1106-1119. PubMed ID: 28731783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Processing of CD74 by the Intramembrane Protease SPPL2a Is Critical for B Cell Receptor Signaling in Transitional B Cells.
    Hüttl S; Kläsener K; Schweizer M; Schneppenheim J; Oberg HH; Kabelitz D; Reth M; Saftig P; Schröder B
    J Immunol; 2015 Aug; 195(4):1548-63. PubMed ID: 26157172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The intramembrane proteases signal Peptide peptidase-like 2a and 2b have distinct functions in vivo.
    Schneppenheim J; Hüttl S; Mentrup T; Lüllmann-Rauch R; Rothaug M; Engelke M; Dittmann K; Dressel R; Araki M; Araki K; Wienands J; Fluhrer R; Saftig P; Schröder B
    Mol Cell Biol; 2014 Apr; 34(8):1398-411. PubMed ID: 24492962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deficiency of the Intramembrane Protease SPPL2a Alters Antimycobacterial Cytokine Responses of Dendritic Cells.
    Gradtke AC; Mentrup T; Lehmann CHK; Cabrera-Cabrera F; Desel C; Okakpu D; Assmann M; Dalpke A; Schaible UE; Dudziak D; Schröder B
    J Immunol; 2021 Jan; 206(1):164-180. PubMed ID: 33239420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measurement of CD74 N-terminal Fragment Accumulation in Cells Treated with SPPL2a Inhibitor.
    Martínez-Barricarte R; Kong XF; Casanova JL
    Bio Protoc; 2019 Jun; 9(11):e3254. PubMed ID: 33654779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The intramembrane protease SPPL2A is critical for tooth enamel formation.
    Bronckers AL; Gueneli N; Lüllmann-Rauch R; Schneppenheim J; Moraru AP; Himmerkus N; Bervoets TJ; Fluhrer R; Everts V; Saftig P; Schröder B
    J Bone Miner Res; 2013 Jul; 28(7):1622-30. PubMed ID: 23426979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The intramembrane protease SPPL2a promotes B cell development and controls endosomal traffic by cleavage of the invariant chain.
    Schneppenheim J; Dressel R; Hüttl S; Lüllmann-Rauch R; Engelke M; Dittmann K; Wienands J; Eskelinen EL; Hermans-Borgmeyer I; Fluhrer R; Saftig P; Schröder B
    J Exp Med; 2013 Jan; 210(1):41-58. PubMed ID: 23267015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamic association of the intramembrane proteases SPPL2a/b and their substrates with tetraspanin-enriched microdomains.
    Leinung N; Mentrup T; Patel M; Gallagher T; Schröder B
    iScience; 2023 Oct; 26(10):107819. PubMed ID: 37736044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Influence of MHC Class II on B Cell Defects Induced by Invariant Chain/CD74 N-Terminal Fragments.
    Schneppenheim J; Loock AC; Hüttl S; Schweizer M; Lüllmann-Rauch R; Oberg HH; Arnold P; Lehmann CHK; Dudziak D; Kabelitz D; Lucius R; Lennon-Duménil AM; Saftig P; Schröder B
    J Immunol; 2017 Jul; 199(1):172-185. PubMed ID: 28550201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The intramembrane protease Sppl2a is required for B cell and DC development and survival via cleavage of the invariant chain.
    Beisner DR; Langerak P; Parker AE; Dahlberg C; Otero FJ; Sutton SE; Poirot L; Barnes W; Young MA; Niessen S; Wiltshire T; Bodendorf U; Martoglio B; Cravatt B; Cooke MP
    J Exp Med; 2013 Jan; 210(1):23-30. PubMed ID: 23267013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Signal-peptide-peptidase-like 2a (SPPL2a) is targeted to lysosomes/late endosomes by a tyrosine motif in its C-terminal tail.
    Behnke J; Schneppenheim J; Koch-Nolte F; Haag F; Saftig P; Schröder B
    FEBS Lett; 2011 Oct; 585(19):2951-7. PubMed ID: 21896273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The intramembrane proteases SPPL2a and SPPL2b regulate the homeostasis of selected SNARE proteins.
    Ballin M; Griep W; Patel M; Karl M; Mentrup T; Rivera-Monroy J; Foo B; Schwappach B; Schröder B
    FEBS J; 2023 May; 290(9):2320-2337. PubMed ID: 36047592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Cell-Based Assay Reveals Nuclear Translocation of Intracellular Domains Released by SPPL Proteases.
    Mentrup T; Häsler R; Fluhrer R; Saftig P; Schröder B
    Traffic; 2015 Aug; 16(8):871-92. PubMed ID: 25824657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atherogenic LOX-1 signaling is controlled by SPPL2-mediated intramembrane proteolysis.
    Mentrup T; Theodorou K; Cabrera-Cabrera F; Helbig AO; Happ K; Gijbels M; Gradtke AC; Rabe B; Fukumori A; Steiner H; Tholey A; Fluhrer R; Donners M; Schröder B
    J Exp Med; 2019 Apr; 216(4):807-830. PubMed ID: 30819724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Fas ligand intracellular domain is released by ADAM10 and SPPL2a cleavage in T-cells.
    Kirkin V; Cahuzac N; Guardiola-Serrano F; Huault S; Lückerath K; Friedmann E; Novac N; Wels WS; Martoglio B; Hueber AO; Zörnig M
    Cell Death Differ; 2007 Sep; 14(9):1678-87. PubMed ID: 17557115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Latest emerging functions of SPP/SPPL intramembrane proteases.
    Mentrup T; Fluhrer R; Schröder B
    Eur J Cell Biol; 2017 Aug; 96(5):372-382. PubMed ID: 28366434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.